QUAGLINO, Elena
Dettaglio
QUAGLINO, Elena
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Pubblicazioni
Risultati 1 - 20 di 93 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues | 2015 | Prato, Mauro; Magnetto, Chiara; Jose, Jithin; Khadjavi, Amina; Cavallo, Federica; Quaglino, Elena; Panariti, Alice; Rivolta, Ilaria; Benintende, Emilio; Varetto, Gianfranco; Argenziano, Monica; Troia, Adriano; Cavalli, Roberta; Guiot, Caterina |
2 | A better immune reaction to Erbb-2 | 2010 | Quaglino E; Mastini C; Riccardo F; Ercole E; Montani M; Forni G; Cavallo F |
3 | A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins | 2010 | Quaglino E; Mastini C; Amici A; Marchini C; Iezzi M; Lanzardo S; De Giovanni C; Montani M; Lollini PL; Masucci G; Forni G; Cavallo F. |
4 | A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. | 2001 | Cifaldi L; Quaglino E; Di Carlo E; Musiani P; Spadaro M; Lollini PL; Wolf S; Boggio K; Forni G; Cavallo F. |
5 | A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice | 2005 | LO IACONO M; CAVALLO F; QUAGLINO E; ROLLA S; IEZZI M; PUPA SM; DE GIOVANNI C; LOLLINI PL; MUSIANI P; FORNI G; CALOGERO RA |
6 | Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. | 2000 | Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G. |
7 | Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. | 2000 | BOGGIO K;DI CARLO E;ROVERO S;CAVALLO F;QUAGLINO E;LOLLINI PL;NANNI P;NICOLETTI G;WOLF S;MUSIANI P;FORNI G |
8 | Antitumor immunization of mothers delays tumor development in cancer-prone offspring | 2015 | Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica |
9 | Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer | 2016 | Jacca, Sarah; Rolih, Valeria; Quaglino, Elena; Franceschi, Valentina; Tebaldi, Giulia; Bolli, Elisabetta; Rosamilia, Alfonso; Ottonello, Simone; Cavallo, Federica; Donofrio, Gaetano |
10 | Breast cancer stem cell antigens as targets for immunotherapy | 2020 | Quaglino E.; Conti L.; Cavallo F. |
11 | Cancer stem cell antigens as targets for new combined anti-cancer therapies | 2020 | Quaglino E.; Cavallo F.; Conti L. |
12 | Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. | 2014 | Riccardo F;Arigoni M;Buson G;Zago E;Iezzi M;Longo D;Carrara M;Fiore A;Nuzzo S;Bicciato S;Nanni P;Landuzzi L;Cavallo F;Calogero R;Quaglino E |
13 | Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. | 2017 | F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino |
14 | Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity. | 2010 | Jacob JB; Quaglino E; Radkevich-Brown O; Jones RF; Piechocki MP; Reyes JD; Weise A; Amici A; Wei WZ. |
15 | Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions | 2004 | QUAGLINO E; ROLLA S; IEZZI M; SPADARO M; MUSIANI P; DE GIOVANNI C; LOLLINI PL; LANZARDO S; FORNI G; SANGES R; CRISPI S; DE LUCA P; CALOGERO R; CAVALLO F. |
16 | Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten | 2010 | Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V. |
17 | Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues | 2015 | Gündisch, Sibylle; Annaratone, Laura; Beese, Christian; Drecol, Enken; Marchiò, Caterina; Quaglino, Elena; Sapino, Anna; Becker, Karl-Friedrich; Bussolati, Gianni |
18 | CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA | 2014 | F. Riccardo; S. Iussich; L. Maniscalco; S. Lorda Mayayo; G. L. Rosa; M. Arigoni; R. De Maria; F. Gattino; S. Lanzardo; E. Lardone; M. Martano; E. Morello; S. Prestigio; A. Fiore; E. Quaglino; S. Zabarino; S. Ferrone; P. Buracco; F. Cavallo |
19 | CSPG4: a prototype oncoantigen for translational immunotherapy studies | 2017 | Rolih, Valeria; Barutello, Giuseppina; Iussich, Selina; De Maria, Raffaella; Quaglino, Elena; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica |
20 | Dendritic cells transfected with ErbB-2 rat/human hybrid plasmid elicit an effective T cells response in ErbB-2+ cancer patients | 2011 | Sergio Occhipinti; Laura Sponton; Cristiana Caorsi; Augusto Amici; Cristina Marchini; Elena Quaglino; Anna Novarino; Michela Donadio; Francesco Novelli; Mirella Giovarelli |